Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$98.98 - $115.74 $3.99 Million - $4.66 Million
40,300 Added 14.36%
321,000 $37.1 Million
Q2 2023

Aug 03, 2023

BUY
$96.34 - $112.38 $27 Million - $31.5 Million
280,700 New
280,700 $28.9 Million
Q1 2023

May 15, 2023

SELL
$107.32 - $113.5 $4.04 Million - $4.27 Million
-37,600 Closed
0 $0
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $2.35 Million - $4.28 Million
37,600 New
37,600 $4.28 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Fifth Lane Capital, LP Portfolio

Follow Fifth Lane Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Lane Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Lane Capital, LP with notifications on news.